| 000 | 01731 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517203856.0 | ||
| 264 | 0 | _c20191104 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a1476-5543 | ||
| 024 | 7 |
_a10.1038/s41372-018-0087-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShimokaze, Tomoyuki | |
| 245 | 0 | 0 |
_aBlood potassium and urine aldosterone after doxapram therapy for preterm infants. _h[electronic resource] |
| 260 |
_bJournal of perinatology : official journal of the California Perinatal Association _c06 2018 |
||
| 300 |
_a702-707 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAldosterone _xurine |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDoxapram _xadverse effects |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGestational Age |
| 650 | 0 | 4 | _aHospitals, Pediatric |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypokalemia _xchemically induced |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aInfant, Premature |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aRespiratory Distress Syndrome, Newborn _xdiagnosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aXanthines _xadverse effects |
| 700 | 1 | _aToyoshima, Katsuaki | |
| 700 | 1 | _aShibasaki, Jun | |
| 700 | 1 | _aItani, Yasufumi | |
| 773 | 0 |
_tJournal of perinatology : official journal of the California Perinatal Association _gvol. 38 _gno. 6 _gp. 702-707 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41372-018-0087-x _zAvailable from publisher's website |
| 999 |
_c28155645 _d28155645 |
||